Search All Resources
Tribal Sovereignty and Harm Reduction | July 6, 2021
Type: Past Presentation
Audience: Clinical
Program: Harm Reduction
Keywords: #health policy #tribal sovereignty
In this presentation, Elizabeth J. Coronado, JD (Chukchansi) of the Northwest Portland Area Indian Health Board's Health Policy team discusses Tribal Sovereignty, it's history, law and policies and shares valuable legal tools for harm reduction.
Date added: 07/6/21
Novel Buprenorphine Induction Strategies | July 6, 2021
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #buprenorphine #novel buprenorphine induction
In this presentation, Dr. Gasper discusses novel buprenorphine induction strategies.
Date added: 07/6/21
Recruiting for PrEP Candidates | July 2, 2021
Type: Past Presentation
Audience: Clinical
Program: PrEP (Pre-Exposure Prophylaxis)
Keywords: #pre-exposure prophylaxis #prep #prep initiation #teleprep
In this presentation, Leslie Stewart, MD, infectious diseases physician for Chinle Hospital (Navajo Nation), shares provider based interventions to increase PrEP, effective strategies for patient education and engagement, and innovative strategies for PrEP delivery, including a focus on mobile clinics, ...
Date added: 07/2/21
Managing Pain in Patients with Substance Use Disorder | July 1, 2021
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder
Keywords: #pain and addiction #pain care #pain management
Dr. Jonathan Robbins, Internal Medicine Physician at OHSU, shows how the neurobiology of pain mirrors the neurobiology of addiction and identifies ways to improve pain management in patients with substance use disorders.
Date added: 07/1/21
Monitoring the Patient While on PrEP/Addressing Complications – Part 2 | June 25, 2021
Type: Past Presentation
Audience: Clinical
Program: PrEP (Pre-Exposure Prophylaxis)
Keywords: #pep #post-exposure prophylaxis #pre-exposure prophylaxis #prep
In this presentation, Janet Cifuentes, PharmD, Clinical Pharmacist at the Phoenix Indian Medical Center, discusses lab monitoring for people on PrEP, side effects of medication and adherence considerations, details on how and when to transition from non-occupational PEP to PrEP, ...
Date added: 06/25/21
Screening for Hepatocellular Carcinoma | June 23, 2021
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcc #hepatocellular carcinoma
Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. In this presentation, Dr. Jon Gerry, surgeon and physician at Franz Liver Cancer Clinic, Providence Portland Medical ...
Date added: 06/23/21
Where do we go from here?: Healthcare worker wellness after the pandemic | June 17, 2021
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #health of healthcare workers #healthcare workers #survival
In this presentation, Jack Rozel, Medical Director for Resolve Crisis Services of UPMC Western Psychiatric Hospital, shares valuable endurance strategies for survival in extreme conditions and healthcare worker wellness after the pandemic.
Date added: 06/17/21
Having Difficult Conversations: Addressing Stigma | June 15, 2021
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #stigma
In this presentation, CAPT Ted Hall discusses language and stigma relative to substance use disorders, principles of drug addiction and effective treatment, and evidence-based strategies for mitigating stigma and bias.
Date added: 06/15/21
Supportive and Affirming Therapy for Gender-Diverse Youth and their Relatives | June 14, 2021
Type: Past Presentation
Audience: Clinical
Program: Trans & Gender Affirming Care
Keywords: #affirming psychotherapy #gender-diverse youth #psychotherapy
This video walks us through principles for supportive and affirming psychotherapy for gender-diverse youth and their relatives, including specific guidance in four case presentations.
Date added: 06/14/21
Nonalcoholic Fatty Liver Disease (NAFLD) and Diabetes | June 10, 2021
Type: Past Presentation
Audience: Clinical
Program: Diabetes
Keywords: #NAFLD #NASH #nonalcoholic fatty liver disease #nonalcoholic steatohepatitis
Dr. Mary Carol Greenlee, practitioner at Western Slope Endocrinology in Grand Junction, Colorado, discusses the etiology and disease progression of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic steatohepatitis (NASH) in patients with diabetes. Dr. Greenlee outlines common adverse outcomes, recognizing ...
Date added: 06/10/21